118th Congress · HOUSE BILLBILL

H.R. 1613 — Drug Price Transparency in Medicaid Act of 2023

“To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program.”

Health

Introduced Mar 17, 2023

Last action Mar 24, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 17, 2023

Step 2

Referred

Mar 24, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 24, 2023

Referred to the Subcommittee on Health.

Mar 17, 2023

Introduced in House

Mar 17, 2023

Referred to the House Committee on Energy and Commerce.